Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy

被引:2
|
作者
Inagaki, Tomonori [1 ]
Hashizume, Atsushi [1 ,2 ]
Hijikata, Yasuhiro [1 ]
Yamada, Shinichiro [1 ]
Ito, Daisuke [1 ]
Kishimoto, Yoshiyuki [1 ]
Torii, Ryota [1 ]
Sato, Hiroyuki [3 ]
Hirakawa, Akihiro [3 ]
Katsuno, Masahisa [1 ,2 ]
机构
[1] Nagoya Univ, Dept Neurol, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Dept Clin Res Educ, Grad Sch Med, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan
[3] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Clin Biostat, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan
关键词
ANDROGEN RECEPTOR; OUTCOME MEASURES; NATURAL-HISTORY; DISEASE; BIOMARKER; THERAPEUTICS; PERFORMANCE; LEUPRORELIN; MODELS; ATAXIA;
D O I
10.1038/s41598-022-22322-w
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
This study aimed to develop a functional measurement that combines quantitative motor evaluation index of various body regions in patients with spinal and bulbar muscular atrophy (SBMA). We assessed subjects with SBMA and healthy controls with quantitative muscle strength measurements and functional scales. We selected tongue pressure, grip power, % peak expiratory flow (%PEF), timed walking test, and % forced vital capacity (%FVC) as components. By combining these values with Z-score, we created a functional composite (SBMA functional composite: SBMAFC). We also calculated the standardized response mean to compare the sensitivity of SBMAFC with that of existing measurements. A total of 97 genetically confirmed patients with SBMA and 36 age- and sex-matched healthy controls were enrolled. In the longitudinal analysis, the standardized response mean of SBMAFC was larger than that of existing rating scales. Receiver operating characteristic (ROC) analysis demonstrated that the SBMAFC is capable of distinguishing between subjects with early-stage SBMA and healthy controls. SBMAFC is more sensitive to disease progression than existing functional rating scales and is a potential outcome measure in clinical trials of SBMA.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] An autopsy case of coexisting spinal and bulbar muscular atrophy and multiple system atrophy
    Miura, Motoki
    Shintaku, Hiroshi
    Numasawa, Yoshiyuki
    Ozaki, Kokoro
    Kanouchi, Tadashi
    Ishikawa, Kinya
    Yokota, Takanori
    NEUROPATHOLOGY, 2025,
  • [42] Difference in chronological changes of outcome measures between untreated and placebo-treated patients of spinal and bulbar muscular atrophy
    Hashizume, Atsushi
    Katsuno, Masahisa
    Banno, Haruhiko
    Suzuki, Keisuke
    Suga, Noriaki
    Tanaka, Fumiaki
    Sobue, Gen
    JOURNAL OF NEUROLOGY, 2012, 259 (04) : 712 - 719
  • [43] Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
    Yamada, Shinichiro
    Hashizume, Atsushi
    Hijikata, Yasuhiro
    Inagaki, Tomonori
    Ito, Daisuke
    Kishimoto, Yoshiyuki
    Kinoshita, Fumie
    Hirakawa, Akihiro
    Shimizu, Shinobu
    Nakamura, Tomohiko
    Katsuno, Masahisa
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2022, 9 (11): : 1702 - 1714
  • [44] Tongue pressure as a novel biomarker of spinal and bulbar muscular atrophy
    Mano, Tomoo
    Katsuno, Masahisa
    Banno, Haruhiko
    Suzuki, Keisuke
    Suga, Noriaki
    Hashizume, Atsushi
    Araki, Amane
    Watanabe, Hirohisa
    Tanaka, Seiya
    Yamamoto, Masahiko
    Sobue, Gen
    NEUROLOGY, 2014, 82 (03) : 255 - 262
  • [45] J wave syndromes in patients with spinal and bulbar muscular atrophy
    Steinmetz, Karoline
    Rudic, Boris
    Borggrefe, Martin
    Muller, Kathrin
    Siebert, Reiner
    Rottbauer, Wolfgang
    Ludolph, Albert
    Buckert, Dominik
    Rosenbohm, Angela
    JOURNAL OF NEUROLOGY, 2022, 269 (07) : 3690 - 3699
  • [46] Impaired muscle uptake of creatine in spinal and bulbar muscular atrophy
    Hijikata, Yasuhiro
    Katsuno, Masahisa
    Suzuki, Keisuke
    Hashizume, Atsushi
    Araki, Amane
    Yamada, Shinichiro
    Inagaki, Tomonori
    Iida, Madoka
    Noda, Seiya
    Nakanishi, Hirotaka
    Banno, Haruhiko
    Mano, Tomoo
    Hirakawa, Akihiro
    Adachi, Hiroaki
    Watanabe, Hirohisa
    Yamamoto, Masahiko
    Sobue, Gen
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (07): : 537 - 546
  • [47] Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy
    Guber, Robert D.
    Takyar, Varun
    Kokkinis, Angela
    Fox, Derrick A.
    Alao, Hawwa
    Kats, Ilona
    Bakar, Dara
    Remaley, Alan T.
    Hewitt, Stephen M.
    Kleiner, David E.
    Liu, Chia-Ying
    Hadigan, Colleen
    Fischbeck, Kenneth H.
    Rotman, Yaron
    Grunseich, Christopher
    NEUROLOGY, 2017, 89 (24) : 2481 - 2490
  • [48] Protein biomarker signature in patients with spinal and bulbar muscular atrophy
    Tebbenkamp, Andrew T. N.
    Huggett, Spencer B.
    Lombardi, Vittoria
    Zampedri, Luca
    Alqahtani, Abdullah
    Kokkinis, Angela
    Malaspina, Andrea
    Rinaldi, Carlo
    Grunseich, Christopher
    Fratta, Pietro
    Viglietta, Vissia
    JCI INSIGHT, 2024, 9 (13)
  • [49] Endoplasmic reticulum stress in spinal and bulbar muscular atrophy: a potential target for therapy
    Montague, Karli
    Malik, Bilal
    Gray, Anna L.
    La Spada, Albert R.
    Hanna, Michael G.
    Szabadkai, Gyorgy
    Greensmith, Linda
    BRAIN, 2014, 137 : 1894 - 1906
  • [50] A phenotypically robust model of spinal and bulbar muscular atrophy in Drosophila
    Richardson, Kristin
    Sengupta, Medha
    Sujkowski, Alyson
    Libohova, Kozeta
    Harris, Autumn C.
    Wessells, Robert
    Merry, Diane E.
    Todi, Sokol V.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2024, 102 (01)